Skip to Content
Merck

42000301

PRONOVA® UP MVM

medium viscosity sodium alginate, viscosity >200 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 %

Slide 1 of 1
Sign In to View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

UNSPSC Code:
12162002
NACRES:
NA.25

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

form

powder

mol wt

Mw >200 kDa (approximate)

composition

mannuronate monomer units, ≥50%
G/M ratio, ≤1

impurities

≤100 CFU/g Total viable count
≤100 EU/g Endotoxins

pH

5.5-8.5 (20 °C, 1% in water)

viscosity

>200 mPa.s, 1 %(20 °C) (
low)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
420006014200010142000501
PRONOVA® UP MVM medium viscosity sodium alginate, viscosity >200 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 %

Sigma-Aldrich

42000301

PRONOVA® UP MVM

Sigma-Aldrich

Sigma-Aldrich

42000601

PRONOVA® UP VLVM

PRONOVA® UP MVG medium viscosity sodium alginate, viscosity >200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 %

Sigma-Aldrich

42000101

PRONOVA® UP MVG

Sigma-Aldrich

Sigma-Aldrich

42000501

PRONOVA® UP VLVG

viscosity

>200 mPa.s, 1 %(20 °C) (
low)

viscosity

<20 mPa.s, 1 %(20 °C) (
low)

viscosity

>200 mPa.s, 1 %(20 °C) (
low)

viscosity

<20 mPa.s, 1 %(20 °C) (
low)

form

powder

form

powder

form

powder

form

powder

mol wt

Mw >200 kDa (approximate)

mol wt

Mw <75 kDa (approximate)

mol wt

Mw >200 kDa (approximate)

mol wt

Mw <75 kDa (approximate)

composition

mannuronate monomer units, ≥50%

composition

mannuronate monomer units, ≥50% , G/M ratio, ≥1.5

composition

guluronate monomer units, ≥60% , G/M ratio, ≥1.5

composition

guluronate monomer units, ≥60% , G/M ratio, ≥1.5

impurities

≤100 CFU/g Total viable count

impurities

≤100 CFU/g Total viable count, ≤100 EU/g Endotoxins

impurities

≤100 CFU/g Total viable count, ≤100 EU/g Endotoxins

impurities

≤100 CFU/g Total viable count, ≤100 EU/g Endotoxins

pH

5.5-8.5 (20 °C, 1% in water)

pH

5.5-8.5 (20 °C, 1% in water)

pH

5.5-8.5 (20 °C, 1% in water)

pH

5.5-8.5 (20 °C, 1% in water)

General description

PRONOVA UP MVM is a medium viscosity (>200 mPas) sodium alginate where minimum 50% of the monomer units are mannuronate.

Application

Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.

Legal Information

Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.

Disclaimer

NOT FOR USE IN HUMANS

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service